FibroGen(FGEN) - 2023 Q3 - Earnings Call Transcript

FibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Conference Call November 6, 2023 5:00 PM ET Company Participants David DeLucia - Head of Corporate FP&A / Investor Relations Thane Wettig - Chief Executive Officer Juan Graham - Chief Financial Officer John Hunter - Chief Scientific Officer Mark Eisner - Chief Medical Officer Chris Chung - Senior Vice President of China Operations Conference Call Participants Operator Hello and welcome to the FibroGen's Third Quarter 2023 Earnings Call. At this time, all partici ...